These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18577314)

  • 1. Integrating medical abortion into safe abortion services: experience from three pilot sites in South Africa.
    Kawonga M; Blanchard K; Cooper D; Cullingworth L; Dickson K; Harrison T; von Mollendorf C; Winikoff B
    J Fam Plann Reprod Health Care; 2008 Jul; 34(3):159-64. PubMed ID: 18577314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introducing medication abortion into public sector facilities in KwaZulu-Natal, South Africa: an operations research study.
    Blanchard K; Lince-Deroche N; Fetters T; Devjee J; de Menezes ID; Trueman K; Sudhinaraset M; Nkonko E; Moodley J
    Contraception; 2015 Oct; 92(4):330-8. PubMed ID: 26162575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assessment of eligibility for early medical abortion using m-Health to calculate gestational age in Cape Town, South Africa: a feasibility pilot study.
    Momberg M; Harries J; Constant D
    Reprod Health; 2016 Apr; 13():40. PubMed ID: 27084750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan.
    Louie KS; Tsereteli T; Chong E; Aliyeva F; Rzayeva G; Winikoff B
    Eur J Contracept Reprod Health Care; 2014 Dec; 19(6):457-64. PubMed ID: 25047120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
    Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline survey on functioning of abortion services in government approved CAC centers in three pilot districts of Nepal.
    Karki C; Ojha M; Rayamajhi RT
    Kathmandu Univ Med J (KUMJ); 2009; 7(25):31-9. PubMed ID: 19483450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
    Robson SC; Kelly T; Howel D; Deverill M; Hewison J; Lie ML; Stamp E; Armstrong N; May CR
    Health Technol Assess; 2009 Nov; 13(53):1-124, iii-iv. PubMed ID: 19906334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accessing medical and surgical first-trimester abortion services: women's experiences and costs from an operations research study in KwaZulu-Natal Province, South Africa.
    Lince-Deroche N; Fetters T; Sinanovic E; Blanchard K
    Contraception; 2017 Aug; 96(2):72-80. PubMed ID: 28390854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'It hurts, but I don't have a choice, I'm not working and I'm sick': decisions and experiences regarding abortion of women living with HIV in Cape Town, South Africa.
    Orner P; de Bruyn M; Cooper D
    Cult Health Sex; 2011 Aug; 13(7):781-95. PubMed ID: 21656408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home self-administration of misoprostol for medical abortion up to 56 days' gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    J Fam Plann Reprod Health Care; 2005 Jul; 31(3):189-92. PubMed ID: 16105279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S.
    Chong E; Frye LJ; Castle J; Dean G; Kuehl L; Winikoff B
    Contraception; 2015 Sep; 92(3):215-9. PubMed ID: 26142620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doing more for less: identifying opportunities to expand public sector access to safe abortion in South Africa through budget impact analysis.
    Lince-Deroche N; Harries J; Constant D; Morroni C; Pleaner M; Fetters T; Grossman D; Blanchard K; Sinanovic E
    Contraception; 2018 Feb; 97(2):167-176. PubMed ID: 28780240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's experiences seeking informal sector abortion services in Cape Town, South Africa: a descriptive study.
    Gerdts C; Raifman S; Daskilewicz K; Momberg M; Roberts S; Harries J
    BMC Womens Health; 2017 Oct; 17(1):95. PubMed ID: 28969631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is self-assessment of medical abortion using a low-sensitivity pregnancy test combined with a checklist and phone text messages feasible in South African primary healthcare settings? A randomized trial.
    Constant D; Harries J; Daskilewicz K; Myer L; Gemzell-Danielsson K
    PLoS One; 2017; 12(6):e0179600. PubMed ID: 28640845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication abortion in the private sector in South Africa.
    Blanchard K; Schaffer K; McLeod S; Winikoff B
    Eur J Contracept Reprod Health Care; 2006 Dec; 11(4):285-90. PubMed ID: 17484194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam.
    Ngoc NT; Nhan VQ; Blum J; Mai TT; Durocher JM; Winikoff B
    BJOG; 2004 Aug; 111(8):814-9. PubMed ID: 15270929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracervical block as pain treatment during second-trimester medical termination of pregnancy: an RCT with bupivacaine versus sodium chloride.
    Andersson IM; Benson L; Christensson K; Gemzell-Danielsson K
    Hum Reprod; 2016 Jan; 31(1):67-74. PubMed ID: 26573530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of women's, providers' and ultrasound assessments of pregnancy duration among termination of pregnancy clients in South Africa.
    Blanchard K; Cooper D; Dickson K; Cullingworth L; Mavimbela N; von Mollendorf C; van Bogaert LJ; Winikoff B
    BJOG; 2007 May; 114(5):569-75. PubMed ID: 17439565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.